If you are enjoying some shockingly mild August weather like us here in the Washington DC area, feel free to bookmark this latest collection of recommended reading for the biotech enthusiast and read another day!
Patients clamor to get into trials for immunotherapy, the new frontier in cancer treatment
Todd Ackerman (Houston Chronicle)
Patient Death Does Not Augur Doom, But Kite Pharma Needs To Shut Its Big Mouth
Matthew Herper (Forbes) $KITE
A shattering crash, an online chronicle, and an unexpected twist: In the age of social media, patients who test experimental treatments wield surprising clout
Rebecca Robbins (STAT / Boston Globe) $NVIV
Dr. Frances Kelsey: American Hero, Government Regulator
Stewart Lyman (Xconomy) - on the death of one of the FDA's most well-known employees. $CELG
-A terrific companion read is the "Autobiographical Reflections" of Dr. Kelsey published by the FDA.
How The FDA Works: A Primer For The Novice Biotech Investor
David Sable (Forbes)
Patients clamor to get into trials for immunotherapy, the new frontier in cancer treatment
Todd Ackerman (Houston Chronicle)
Patient Death Does Not Augur Doom, But Kite Pharma Needs To Shut Its Big Mouth
Matthew Herper (Forbes) $KITE
A shattering crash, an online chronicle, and an unexpected twist: In the age of social media, patients who test experimental treatments wield surprising clout
Rebecca Robbins (STAT / Boston Globe) $NVIV
Dr. Frances Kelsey: American Hero, Government Regulator
Stewart Lyman (Xconomy) - on the death of one of the FDA's most well-known employees. $CELG
-A terrific companion read is the "Autobiographical Reflections" of Dr. Kelsey published by the FDA.
How The FDA Works: A Primer For The Novice Biotech Investor
David Sable (Forbes)
RSS Feed
